ALLO IPSC
Dead / Abandoned — Abandoned — no statement of use filed (as of 01 Jul 2024)
What this means for you
This application is over — abandoned 01 Jul 2024. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 97650057
- Mark type
- Stylized text
- Filed
- 27 Oct 2022
- Published for opposition
- 04 Apr 2023
- Abandoned
- 01 Jul 2024
- Attorney of record
- Jason S. Howell
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations, namely, preparations for use in the treatment of cancer and tumors; pharmaceutical and biological preparations for immunotherapy, including T Cell therapy
Owner
- Allogene Therapeutics, Inc., South San Francisco, CA, US
- Allogene Therapeutics, Inc., South San Francisco, CA, US
Prosecution history
- 12 Jul 2024 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 01 Jul 2024 — ABANDONMENT - NO USE STATEMENT FILED
- 27 Oct 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 25 Oct 2023 — SOU EXTENSION 1 GRANTED
- 25 Oct 2023 — SOU EXTENSION 1 FILED
- 25 Oct 2023 — SOU TEAS EXTENSION RECEIVED
- 30 May 2023 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 04 Apr 2023 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 15 Mar 2023 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 28 Feb 2023 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 28 Feb 2023 — EXAMINER'S AMENDMENT ENTERED
- 28 Feb 2023 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 28 Feb 2023 — EXAMINERS AMENDMENT E-MAILED
- 28 Feb 2023 — EXAMINERS AMENDMENT -WRITTEN
- 17 Jan 2023 — NOTIFICATION OF NON-FINAL ACTION E-MAILED